urinary
excretion
estrone
estradiol
estriol
patients
prostatic
cancer
benign
prostatic
hypertrophy
hopkins
c.e
urinary
estrone
estradiol
estriol
fractions
excreted
patients
prostatic
cancer
patients
benign
hypertrophy
clinically
well
subjects
assayed
determine
whether
differences
exist
absolute
levels
estrone
estradiol
estriol
fractions
significantly
different
excretion
relatively
lower
levels
estrone
estradiol
relatively
higher
levels
estriol
patients
prostatic
cancer
compared
clinically
well
subjects
resulted
significantly
lower
proportions
total
estrogen
excreted
estrone
estradiol
differences
proportions
estrogen
frac
tions
patients
benign
hypertrophy
clinically
well
subjects
significant
exception
a
significantly
higher
percentage
total
estrogen
excreted
estrone
patients
benign
hypertrophy
differences
group
cancer
group
also
significant
clinical
variations
groups
within
cancer
hypertrophy
groups
preclude
assignment
significant
differences
prostatic
dystrophies
alone
cancer
patients
experiencing
inanition
due
a
loss
appetite
excreted
significantly
lower
levels
estrone
patients
reported
loss
appetite
significantly
lower
levels
estrone
excreted
patients
benign
hyper
trophy
hospitalized
days
compared
patients
hospitalized
days
less
a
significantly
higher
urinary
estroneandrosterone
ratio
present
cancer
group
clinically
well
group
believed
however
arbi
trary
ratio
used
suggest
internal
estrogenandrogen
imbalance
